Fanny Lalloyer

1.5k total citations
17 papers, 909 citations indexed

About

Fanny Lalloyer is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Fanny Lalloyer has authored 17 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Fanny Lalloyer's work include Peroxisome Proliferator-Activated Receptors (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Fanny Lalloyer is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Fanny Lalloyer collaborates with scholars based in France, Belgium and Netherlands. Fanny Lalloyer's co-authors include Bart Staels, Anne Tailleux, Eric Baugé, Susanne Mandrup, Sandrine Caron, Jan-Ακε Gustafsson, Thomas Åskov Pedersen, Barbara Gross, Catherine Fiévet and Philippe Lefèbvre and has published in prestigious journals such as Molecular and Cellular Biology, Hepatology and Diabetes.

In The Last Decade

Fanny Lalloyer

15 papers receiving 892 citations

Peers

Countries citing papers authored by Fanny Lalloyer

Since Specialization

Citations

This map shows the geographic impact of Fanny Lalloyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Lalloyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Lalloyer more than expected).

Fields of papers citing papers by Fanny Lalloyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Lalloyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Lalloyer. The network helps show where Fanny Lalloyer may publish in the future.

Co-authorship network of co-authors of Fanny Lalloyer

This figure shows the co-authorship network connecting the top 25 collaborators of Fanny Lalloyer. A scholar is included among the top collaborators of Fanny Lalloyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny Lalloyer. Fanny Lalloyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	The evolution of lipid-lowering drugs in the management of cardiovascular disease risk: From the first cardiovascular disease risk–reducing therapies to the novel challenging strategies 2025 ·Pharmacological Reviews ·Doriane Henry, Eric Baugé, Bart Staels, Fanny Lalloyer	0
2	Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr- deficient mice 2025 ·Science Translational Medicine ·Doriane Henry, Eric Baugé, Nathalie Hennuyer, (unknown), Bruno Derudas, Emmanuelle Vallez, Audrey Deprince, Philippe Lefèbvre, Joel T. Haas, Bart Staels, Fanny Lalloyer	0
3	Pemafibrate induces atheroprotection in LDLR deficient mice through hepatocyte transrepression PPARA activity 2023 ·Atherosclerosis ·Doriane Henry, Eric Baugé, Nathalie Hennuyer, Bruno Derudas, Emmanuelle Vallez, Audrey Deprince, Joel T. Haas, Philippe Lefèbvre, Bart Staels, Fanny Lalloyer	1
4	Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity 2021 ·JCI Insight ·(unknown), (unknown), (unknown), (unknown), Karelle Leroy, Fanny Lalloyer, Eric Baugé, Bart Staels, Charles Duyckaerts, Jean‐Pierre Brion, Philippe Gailly, Jean‐Noël Octave, Nathalie Pierrot	16
5	Sex-regulated gene dosage effect of PPARα on synaptic plasticity 2019 ·Life Science Alliance ·Nathalie Pierrot, Laurence Ris, Ilie‐Cosmin Stancu, (unknown), (unknown), Donatienne Tyteca, Eric Baugé, Fanny Lalloyer, (unknown), Olivier Schakman, Karelle Leroy, Pascal Kienlen‐Campard, Philippe Gailly, Jean‐Pierre Brion, Ilse Dewachter, Bart Staels, Jean-Noël Octave	19
6	Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans 2016 ·International Journal of Obesity ·Valeria Spinelli, Fanny Lalloyer, Grégory Baud, Elena Osto, Mostafa Kouach, Mehdi Daoudi, Emmanuelle Vallez, Violeta Raverdy, (unknown), Amandine Descat, (unknown), Thomas Hübert, Thomas A. Lutz, Sophie Lestavel, Bart Staels, François Pattou, Anne Tailleux	63
7	Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα Deficiency 2015 ·Molecular Endocrinology ·Michał Pawlak, Eric Baugé, Fanny Lalloyer, Philippe Lefèbvre, Bart Staels	26
8	The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice 2014 ·Hepatology ·Michał Pawlak, Eric Baugé, William Bourguet, Karolien De Bosscher, Fanny Lalloyer, Anne Tailleux, Corinna Lebherz, Philippe Lefèbvre, Bart Staels	114
9	Genome-Wide Profiling of Liver X Receptor, Retinoid X Receptor, and Peroxisome Proliferator-Activated Receptor α in Mouse Liver Reveals Extensive Sharing of Binding Sites 2011 ·Molecular and Cellular Biology ·Michael Boergesen, Thomas Åskov Pedersen, Barbara Gross, Simon J. van Heeringen, Dik Hagenbeek, Christian Bindesbøll, Sandrine Caron, Fanny Lalloyer, Knut R. Steffensen, Hilde I. Nebb, Jan-Ακε Gustafsson, Hendrik G. Stunnenberg, Bart Staels, Susanne Mandrup	199
10	PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH 2011 ·Atherosclerosis ·Morgane Baron, Aurélie S. Leroyer, Zouher Majd, Fanny Lalloyer, Emmanuelle Vallez, Kadiombo Bantubungi, Giulia Chinetti, Philippe Delerive, Chantal M. Boulanger, Bart Staels, Anne Tailleux	20
11	Peroxisome Proliferator–Activated Receptor-α Gene Level Differently Affects Lipid Metabolism and Inflammation in Apolipoprotein E2 Knock-In Mice 2011 ·Arteriosclerosis Thrombosis and Vascular Biology ·Fanny Lalloyer, Kristiaan Wouters, Morgane Baron, Sandrine Caron, Emmanuelle Vallez, Jonathan Vanhoutte, Eric Baugé, Ronit Shiri‐Sverdlov, Marten H. Hofker, Bart Staels, Anne Tailleux	60
12	Fibrates, Glitazones, and Peroxisome Proliferator–Activated Receptors 2010 ·Arteriosclerosis Thrombosis and Vascular Biology ·Fanny Lalloyer, Bart Staels	173
13	Rexinoid Bexarotene Modulates Triglyceride but not Cholesterol Metabolism via Gene-Specific Permissivity of the RXR/LXR Heterodimer in the Liver 2009 ·Arteriosclerosis Thrombosis and Vascular Biology ·Fanny Lalloyer, Thomas Åskov Pedersen, Barbara Gross, Sophie Lestavel, Saı̈d Yous, Emmanuelle Vallez, Jan-Ακε Gustafsson, Susanne Mandrup, Catherine Fiévet, Bart Staels, Anne Tailleux	66
14	BEXAROTENE-ACTIVATED RXR/LXR HETERODIMER IN LIVER MODULATES TRIGLYCERIDE METABOLISM BUT NOT CHOLESTEROL HOMEOSTASIS IN VIVO 2008 ·Atherosclerosis Supplements ·Fanny Lalloyer, Thomas Åskov Pedersen, Barbara Gross, Saı̈d Yous, Emmanuelle Vallez, (unknown), Susanne Mandrup, Catherine Fiévet, Bart Staels, Anne Tailleux	1
15	The RXR Agonist Bexarotene Improves Cholesterol Homeostasis and Inhibits Atherosclerosis Progression in a Mouse Model of Mixed Dyslipidemia 2006 ·Arteriosclerosis Thrombosis and Vascular Biology ·Fanny Lalloyer, Catherine Fiévet, Sophie Lestavel, Gérard Torpier, (unknown), Véronique Touche, (unknown), Saı̈d Yous, Folkert Kuipers, Réjane Paumelle, Jean‐Charles Fruchart, Bart Staels, Anne Tailleux	63
16	Peroxisome Proliferator–Activated Receptor α Improves Pancreatic Adaptation to Insulin Resistance in Obese Mice and Reduces Lipotoxicity in Human Islets 2006 ·Diabetes ·Fanny Lalloyer, B. Vandewalle, Frédéric Percevault, Gérard Torpier, Julie Kerr‐Conte, Maaike H. Oosterveer, Réjane Paumelle, Jean‐Charles Fruchart, Folkert Kuipers, François Pattou, Catherine Fiévet, Bart Staels	87
17	W15-O-003 Atheroprotective effect of the rexinoid targretin in a murine model of atherosclerosis 2005 ·Atherosclerosis Supplements ·Anne Tailleux, Fanny Lalloyer, Sophie Lestavel, G. Torpier, Saı̈d Yous, J.C. Fruchart, Bart Staels, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact